RAPT Therapeutics, Inc.
RAPT
$0.7479
-$0.1309-14.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.37M | 28.88M | 27.33M | 27.78M | 27.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 122.85M | 136.10M | 114.85M | 128.98M | 128.02M |
| Operating Income | -122.85M | -136.10M | -114.85M | -128.98M | -128.02M |
| Income Before Tax | -116.51M | -129.87M | -107.49M | -120.43M | -118.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -116.51 | -129.87 | -107.49 | -120.43 | -118.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -116.51M | -129.87M | -107.49M | -120.43M | -118.05M |
| EBIT | -122.85M | -136.10M | -114.85M | -128.98M | -128.02M |
| EBITDA | -121.71M | -134.90M | -113.61M | -127.72M | -126.79M |
| EPS Basic | -2.41 | -3.12 | -2.78 | -3.12 | -3.07 |
| Normalized Basic EPS | -1.51 | -1.97 | -1.77 | -1.99 | -1.96 |
| EPS Diluted | -2.41 | -3.12 | -2.78 | -3.12 | -3.07 |
| Normalized Diluted EPS | -1.51 | -1.97 | -1.77 | -1.99 | -1.96 |
| Average Basic Shares Outstanding | 339.87M | 163.08M | 154.78M | 154.23M | 153.70M |
| Average Diluted Shares Outstanding | 339.87M | 163.08M | 154.78M | 154.23M | 153.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |